DISCOUNT ZERTIFIKAT - BIONTECH ADR Share Price

Certificat

DE000PE9SP98

Delayed Deutsche Boerse AG 08:20:29 26/06/2024 BST
76.38 EUR +0.01% Intraday chart for DISCOUNT ZERTIFIKAT - BIONTECH ADR
Current month-7.50%
1 month-5.95%
Date Price Change
26/06/24 76.38 +0.01%
25/06/24 76.37 -1.05%
24/06/24 77.18 +1.66%
21/06/24 75.92 -1.24%
20/06/24 76.87 +0.04%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 08:20 am

More quotes

Static data

Product typeCertificados de Descuento
Buy / SellCALL
Underlying BIONTECH SE
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE9SP9
ISINDE000PE9SP98
Date issued 23/02/2023
Maturity 20/12/2024 (178 Days)
Parity 1 : 1
Emission price 74.89
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 83.52
Lowest since issue 71.22
Spread 0.05
Spread %0.07%

Company Profile

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Sector
-
More about the company

Ratings for BioNTech SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: BioNTech SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
78.84 EUR
Average target price
103.5 EUR
Spread / Average Target
+31.24%
Consensus